Polycythemia vera causes: Difference between revisions
Shyam Patel (talk | contribs) |
Shyam Patel (talk | contribs) |
||
| Line 5: | Line 5: | ||
Polycythemia vera is caused by a mutation in the ''[[JAK2]]'' kinase (V617F) gene.<ref name="pmid15781101">{{cite journal| author=Baxter EJ, Scott LM, Campbell PJ, East C, Fourouclas N, Swanton S et al.| title=Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. | journal=Lancet | year= 2005 | volume= 365 | issue= 9464 | pages= 1054-61 | pmid=15781101 | doi=10.1016/S0140-6736(05)71142-9 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15781101 }} </ref> | Polycythemia vera is caused by a mutation in the ''[[JAK2]]'' kinase (V617F) gene.<ref name="pmid15781101">{{cite journal| author=Baxter EJ, Scott LM, Campbell PJ, East C, Fourouclas N, Swanton S et al.| title=Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. | journal=Lancet | year= 2005 | volume= 365 | issue= 9464 | pages= 1054-61 | pmid=15781101 | doi=10.1016/S0140-6736(05)71142-9 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15781101 }} </ref> | ||
==Common Causes== | ==Common Causes== | ||
Polycythemia vera is caused by a mutation in the ''[[JAK2]]'' gene. This is a member of the Janus kinase family. The most common mutation is point mutation in which valine is replaced by phenylalanine at the 617th position.<ref name="pmid15781101">{{cite journal| author=Baxter EJ, Scott LM, Campbell PJ, East C, Fourouclas N, Swanton S et al.| title=Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. | journal=Lancet | year= 2005 | volume= 365 | issue= 9464 | pages= 1054-61 | pmid=15781101 | doi=10.1016/S0140-6736(05)71142-9 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15781101 }} </ref> This mutation is found in more than 95% of cases of polycythemia vera. The JAK2 exon 12 mutation can also cause polycythemia vera. | Polycythemia vera is caused by a mutation in the ''[[JAK2]]'' gene. This is a member of the Janus kinase family. The most common mutation is point mutation in which valine is replaced by phenylalanine at the 617th position.<ref name="pmid15781101">{{cite journal| author=Baxter EJ, Scott LM, Campbell PJ, East C, Fourouclas N, Swanton S et al.| title=Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. | journal=Lancet | year= 2005 | volume= 365 | issue= 9464 | pages= 1054-61 | pmid=15781101 | doi=10.1016/S0140-6736(05)71142-9 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15781101 }} </ref> This mutation is found in more than 95% of cases of polycythemia vera. The JAK2 exon 12 mutation can also cause polycythemia vera. These mutations are sporadic and occur within the hematopoietic stem cell. Genetic inheritance of JAK2 mutations is unlikely to occur. | ||
==References== | ==References== | ||
Revision as of 04:37, 8 February 2018
|
Polycythemia vera Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Polycythemia vera causes On the Web |
|
American Roentgen Ray Society Images of Polycythemia vera causes |
|
Risk calculators and risk factors for Polycythemia vera causes |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Mohamad Alkateb, MBBCh [2]
Overview
Polycythemia vera is caused by a mutation in the JAK2 kinase (V617F) gene.[1]
Common Causes
Polycythemia vera is caused by a mutation in the JAK2 gene. This is a member of the Janus kinase family. The most common mutation is point mutation in which valine is replaced by phenylalanine at the 617th position.[1] This mutation is found in more than 95% of cases of polycythemia vera. The JAK2 exon 12 mutation can also cause polycythemia vera. These mutations are sporadic and occur within the hematopoietic stem cell. Genetic inheritance of JAK2 mutations is unlikely to occur.
References
- ↑ 1.0 1.1 Baxter EJ, Scott LM, Campbell PJ, East C, Fourouclas N, Swanton S; et al. (2005). "Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders". Lancet. 365 (9464): 1054–61. doi:10.1016/S0140-6736(05)71142-9. PMID 15781101.